Jove
Visualize
Contact Us

Related Experiment Videos

[Pyoderma gangrenosum].

G Moulin1, F Augey

  • 1Service de Dermatologie, Hôpital de l'Antiquaille, Lyon.

Presse Medicale (Paris, France : 1983)
|October 27, 1990
PubMed
Summary
This summary is machine-generated.

Pyoderma gangrenosum is a rare skin condition often diagnosed clinically. While its cause is unknown, treatments like corticosteroids can be effective, and it frequently indicates serious underlying diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinophobia: Dermatologists on the front line (16 cases).

Annales de dermatologie et de venereologie·2021
Same author

Chronic urticaria and hormones: Is there a link?

Journal of the European Academy of Dermatology and Venereology : JEADV·2016
Same author

[Pathophysiology of urticaria].

Annales de dermatologie et de venereologie·2014
Same author

[Why a "urticaria" group of the French dermatological society?].

Annales de dermatologie et de venereologie·2011
Same author

[Chronic urticaria and corticodependence: corticosteroids have no role in the treatment of urticaria].

Annales de dermatologie et de venereologie·2011
Same author

[Heart failure and stasis ulcer: A significant association (prospective study of 100 cases)].

Annales de dermatologie et de venereologie·2010
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Dermatology
  • Internal Medicine

Context:

  • Pyoderma gangrenosum (PG) is a rare, ulcerative skin disease.
  • Diagnosis is primarily clinical, often challenging due to its rarity and lack of specific biomarkers.
  • Distinguishing PG from more common vascular or infectious ulcers is crucial.

Purpose:

  • To review the current understanding of pyoderma gangrenosum.
  • To highlight diagnostic challenges and potential underlying pathologies.
  • To discuss current and potential therapeutic strategies.

Summary:

  • Pyoderma gangrenosum (PG) is characterized by its obscure pathogenesis and varied, often conflicting, reported abnormalities.
  • It is frequently idiopathic or associated with multiple systemic diseases, suggesting it may represent a syndrome divisible into distinct entities.

Related Experiment Videos

  • Despite diagnostic and etiological challenges, systemic corticosteroids, sulfones, or clofazimine offer effective treatment for most patients.
  • A significant association with severe underlying pathologies is noted in nearly 50% of cases.

    • Impact:

    • Emphasizes the importance of considering pyoderma gangrenosum in differential diagnoses of ulcerative lesions.
    • Highlights the need for further research into its pathophysiology to enable more targeted treatments.
    • Underscores the critical association with systemic diseases, necessitating thorough patient evaluation.